Industry News
Opthea Launches Medical Advisory Board with Global Retina Experts

Opthea announced the formation of its Medical Advisory Board (MAB), comprised of ten distinguished t...

read more
Opthea Launches Medical Advisory Board with Global Retina Experts
July 19, 2024
EssilorLuxottica Acquires 80% Stake in Heidelberg Engineering

EssilorLuxottica announced its acquisition of an 80% stake in Heidelberg Engineering, a German compa...

read more
EssilorLuxottica Acquires 80% Stake in Heidelberg Engineering
July 19, 2024
NexThera Submits IND Application for NT-101, a Non-Invasive Treatment for Wet AMD

NexThera has officially submitted a Phase 1/2a Investigational New Drug (IND) application to the U.S...

read more
NexThera Submits IND Application for NT-101, a Non-Invasive Treatment for Wet AMD
July 18, 2024
PulseMedica Secures $12M to Advance Eye Floater Imaging and Treatment Technology

PulseMedica has successfully raised a total of $12 million in their recent pre-Series A financing ro...

read more
PulseMedica Secures $12M to Advance Eye Floater Imaging and Treatment Technology
July 18, 2024
ENTOD Pharmaceuticals Introduces Novel Eye Drop Preservative System

Mumbai-based ENTOD Pharmaceuticals has unveiled a novel advancement in ophthalmic care with the intr...

read more
ENTOD Pharmaceuticals Introduces Novel Eye Drop Preservative System
July 17, 2024
Heidelberg Engineering Receives FDA Clearance for Enhanced SPECTRALIS® OCTA Module

Heidelberg Engineering announced the FDA clearance of its upgraded SPECTRALIS® OCTA Module featuring...

read more
Heidelberg Engineering Receives FDA Clearance for Enhanced SPECTRALIS® OCTA Module
July 17, 2024
Sydnexis Names Perry J. Sternberg as Chief Executive Officer

Sydnexis, Inc., a pioneering biopharmaceutical company dedicated to addressing pediatric myopia prog...

read more
Sydnexis Names Perry J. Sternberg as Chief Executive Officer
July 17, 2024
Merck Completes Acquisition of EyeBio

Merck, known as MSD outside of the United States and Canada, announced the successful completion of ...

read more
Merck Completes Acquisition of EyeBio
July 17, 2024
Okyo Pharma to Initiate Phase 2 Clinical Trial for OK-101 in Neuropathic Corneal Pain

Okyo Pharma announced its plan to initiate a phase 2 clinical trial for OK-101 in the treatment of n...

read more
Okyo Pharma to Initiate Phase 2 Clinical Trial for OK-101 in Neuropathic Corneal Pain
July 16, 2024
Clínica Baviera Acquires UK-Based Optimax Group for €11.7 Million

Clínica Baviera, through its subsidiary Castellana Intermediación Sanitaria, S.L., has finalized the...

read more
Clínica Baviera Acquires UK-Based Optimax Group for €11.7 Million
July 04, 2024
More